Search for: "Anda Pharmaceuticals, Inc"
Results 481 - 500
of 607
Sorted by Relevance
|
Sort by Date
12 Jul 2022, 2:08 am
Defendants HEC Pharm Co., Ltd. and HEC Pharm USA Inc. appealed. [read post]
8 Jul 2009, 7:04 am
– CAFC decision in Agilent Techs v Affymetrix concerning claims pertaining to ‘microarray hybridization’ (Gray on Claims) US: Counterclaims dismissed in Alzheimer’s Institute/ Mayo patent licensing dispute over transgenic mice (Patent Docs) Products (Tavanic) Levofloxacin – UK: EWCA upholds decision that Daiichi’s Levofloxacin patent and SPC both invalid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd and Daiichi… [read post]
19 Feb 2024, 12:55 pm
Teva and Apotex, filed Abbreviated New Drug Applications (ANDAs) with the FDA seeking to market generic versions of the $100m+ drug. [read post]
2 Aug 2012, 10:17 am
Mutual markets the drug under an ANDA FDA approved in 1991 (ANDA No. 072051). [read post]
3 Feb 2010, 2:00 am
Johnson & Johnson Inc. et al. [read post]
16 Aug 2010, 12:13 pm
Adams Respiratory Therapeutics, Inc. v. [read post]
8 Oct 2009, 6:05 am
Teva Pharmaceuticals USA, Inc (Patent Docs) (Patent Baristas) (GenericsWeb) General Biotech legislative agenda: healthcare, energy, patents and capital (IP Watch) India: Applying for patents does pay: Wockhardt wins kudos from the Indian government (SPICY IP) US: CAFC ruling in Board of Trustees of the Leland Stanford Junior University et al v Roche Molecular Systems et al - How to lose a patent? [read post]
14 Dec 2007, 1:00 am
Gore & Associates Inc. held to have willfully infringed rival C.R. [read post]
5 Aug 2010, 11:06 pm
Andrx Pharmaceuticals, Inc., 344 F.3d 1226, 1234 (Fed. [read post]
27 Jul 2011, 1:01 am
Paddock Laboratories, Inc. [read post]
5 Aug 2009, 5:35 am
(Spicy IP) Coversyl (Perindopril) – Canada: Court of Appeal upholds Trial Division finding of patent validity and infringement: Apotex v ADIR (Pharmacapsules@Gowlings) Cozaar (Losartan) – France: French Patent Office grants paediatric extension of French SPC for Losartan (The SPC Blog) Cozaar/Hyzaar (Losartan) – US: FDA prevails in generic Cozaar/Hyzaar 180-day exclusivity forfeiture litigation: Teva Pharmaceuticals v Sebelius (FDA Law Blog) Diflucan… [read post]
31 Oct 2013, 5:00 am
APP Pharmaceuticals, LLC, 2013 WL 5532767 (D. [read post]
14 Jul 2016, 2:37 pm
Hospira Inc., Federal Circuit case number 2014-1469, that to be “on sale” under pre-AIA 35 U.S.C. [read post]
8 May 2019, 7:14 am
Genus Lifesciences Inc. v. [read post]
6 Apr 2011, 12:18 am
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive patent… [read post]
22 Dec 2010, 3:01 am
-Florida (Patent Docs) FazaClo (Clozapine): US – Patent infringement complaint filed following a Paragraph IV certification: Mylan Pharmaceuticals Inc. v. [read post]
27 Oct 2006, 9:43 am
" Life Techs., Inc. v. [read post]
30 May 2011, 6:34 pm
Karst – Last Friday, Nostrum Pharmaceuticals, LLC (“Nostrum”) lodged a Complaint against FDA in the U.S. [read post]
21 Jul 2011, 10:48 pm
See Schwarz Pharma, Inc. v. [read post]
30 Jan 2009, 9:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: AIPLA urges Federal Circuit not to proscribe patents for biomedical diagnostic tools: Prometheus v Mayo (Inventive Step) (Hal Wegner) (Patently-O) (Holman's Biotech IP Blog) Lovenox (Enoxaparin) – US: Aventis files for certiorari: challenging Federal Circuit’s low standard for intent to deceive in inequitable… [read post]
